Revance Therapeutic (RVNC) PT Lowered to $25 at Needham & Company

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Revance Therapeutic (RVNC) PT Lowered to $25 at Needham & Company

Revance Therapeutic (RVNC) PT Lowered to $26 at Mizuho Securities

October 18, 2021 6:34 AM EDT

Mizuho Securities analyst Difei Yang lowered the price target on Revance Therapeutic (NASDAQ: RVNC) to $26.00 (from $36.00) while maintaining a Buy rating.... More

Revance Therapeutic (RVNC) PT Lowered to $18 at H.C. Wainwright

October 18, 2021 6:33 AM EDT

H.C. Wainwright analyst Douglas Tsao lowered the price target on Revance Therapeutic (NASDAQ: RVNC) to $18.00 (from $26.00) while maintaining a Buy rating.... More

Revance Therapeutics (RVNC) Announces FDA is Unable to Approve DaxibotulinumtoxinA; Management Plans to Request Type A Meeting

October 18, 2021 5:17 AM EDT

(Updated - October 18, 2021 6:40 AM EDT)

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the United States (U.S.) Food and Drug Administration (FDA) has issued a Complete Response Letter, or CRL, regarding the Biologics... More